# Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect

> **NCT04077879** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 97 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ASP1617
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04077879
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-19
- **Primary completion:** 2021-06-12
- **Final completion:** 2021-06-12
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04077879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04077879, "Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04077879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*